Nicotine and cannabinoids: parallels, contrasts and interactions

VIVEROS, M, MARCO, E, FILE, S·2006·Neuroscience & Biobehavioral Reviews
DOI 10.1016/j.neubiorev.2006.08.002

Cites (283)

Items 201–283 of 283

  1. Cannabinoids and the Regulation of Ingestive Behaviour
    Steve P. Vickers, G.A. Kennett · 2005 · Current Drug Targets
  2. Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats
    Elaine E. Irvine, M. Bagnalasta, Clara Marcon, C. Motta, Michela Tessari, Sandra E. File, Cristiano Chiamulera · 2000 · Psychopharmacology
  3. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol
    SARAH FRYER LEIBOWITZ, Constantine Rossakis · 1978 · European Journal of Pharmacology
  4. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide1Published on the World Wide Web on 18 January 2000.1
    Susan J Houser, Micah Eads, James P. Embrey, Sandra P. Welch · 2000 · Brain Research
  5. Risk factors for late relapse in male and female ex-smokers
    Gary E. Swan, Charles E. Denk, Stanley D. Parker, Dorit Carmelli, Cynthia T. Furze, Ray H. Rosenman · 1988 · Addictive Behaviors
  6. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety
    Abdel‐Mouttalib Ouagazzal, Paul J. Kenny, Sandra E. File · 1999 · European Journal of Neuroscience
  7. Social isolation modifies nicotine's effects in animal tests of anxiety
    Cheeta, Survjit, Irvine, Elaine, File, Sandra E · 2001 · British Journal of Pharmacology
  8. Changes in food reward following smoking cessation: a pharmacogenetic investigation
    Caryn E. Lerman, Wade H. Berrettini, Angela G. Pinto, Freda Patterson, Susan Crystal-Mansour, E. Paul Wileyto, StephanieL. Restine, Debra G. B. Leonard, PeterG. Shields, LeonardH. Epstein · 2004 · Psychopharmacology
  9. Differential Effects of Endogenous and Synthetic Cannabinoids on α7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
    Murat Öz, Li Zhang, Arippa Ravindran, Marisela Morales, Carl R. Lupica · 2004 · Journal of Pharmacology and Experimental Therapeutics
  10. Why may teenage girls persist in smoking?
    ARTHUR CRISP, Philip Martin Sedgwick, Christine Halek · 1999 · Journal of Adolescence
  11. The role of the cannabinoid system in nicotine addiction
    Anna Castañé, Fernando Berrendero, Rafael J. Maldonado · 2005 · Pharmacology Biochemistry and Behavior
  12. Comorbid cannabis use and panic disorder: short term and long term follow‐up study
    Pinhas Nadim Dannon, Katherine Lowengrub, Revital Amiaz, Leon J. Grunhaus, Moshe Kotler · 2004 · Human Psychopharmacology Clinical and Experimental
  13. Regulation of Feeding-Associated Peptides and Receptors by Nicotine
    Ming D. Li, Steven L. Parker, Justin K. Kane · 2000 · Molecular Neurobiology
  14. Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus
    Paul J. Kenny, Sandra E. File, Marcus Rattray · 2001 · European Journal of Neuroscience
  15. A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS study
    Manfred S. Green, Gil Harari · 1995 · Journal of Clinical Epidemiology
  16. Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors
    Paul J. Kenny, Survjit Cheeta, Sandra E. File · 2000 · Neuropharmacology
  17. The role of cannabis in supporting young people's cigarette smoking: a qualitative exploration
    Gill Highet · 2004 · Health Education Research
  18. Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats
    Carole Sztalryd, Jock S. Hamilton, Barbara A. Horwitz · 1996 · American Journal of Physiology-Endocrinology and Metabolism
  19. Is marijuana use becoming a ‘gateway’ to nicotine dependence?
    Gary L. Humfleet, Amie L. Haas · 2003 · Addiction
  20. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of α7 receptors
    Sonia A. Tucci, Rachel F. Genn, Sandra E. File · 2003 · Neuropharmacology
  21. Effects of nicotine and mecamylamine on cognition in rhesus monkeys
    Simon N. Katner, Sophia A. Davis, Amber J. Kirsten, Michael A. Taffe · 2004 · Psychopharmacology
  22. Acute Δ9-Tetrahydrocannabinol-Induced Deficits in Reversal Learning: Neural Correlates of Affective Inflexibility
    Alice Egerton, Ros R. Brett, Judith A. Pratt · 2005 · Neuropsychopharmacology
  23. Women Gain Weight 1 Year After Smoking Cessation While Dietary Intake Temporarily Increases
    Bette Jane Caan, Ashley O. Coates, Catherine A. Schaefer, LAURA FINKLER, Barbara Sternfeld, Kitty K. Corbett · 1996 · Journal of the American Dietetic Association
  24. Altered reward value of carbohydrate snacks for female smokers withdrawn from nicotine
    Bonnie J. Spring · 2003 · Pharmacology Biochemistry and Behavior
  25. Smoking expectancy mediates the conditioned responses to arbitrary smoking cues
    Matt Field, Theodora Duka · 2001 · Behavioural Pharmacology
  26. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice
    Graciela Noemí Balerio, Ester Aso, Rafael J. Maldonado · 2005 · Psychopharmacology
  27. Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Δ-9-tetrahydrocannabinol in rats
    Bernard Le Foll, M Wiggins, Steven R. Goldberg · 2006 · Behavioural Pharmacology
  28. Effects of nicotine administered via a transdermal delivery system on vigilance: a repeated measure study
    G. Mancuso, Pilar Andrés, Marc Ansseau, Ezio Tirelli · 1999 · Psychopharmacology
  29. Youth tobacco surveillance United States, 1998-1999
    Cheryl G. Healton, Cheri Ahern, Scott M. Batchelor et al. · 2000 · MMWR Morbidity and Mortality Weekly Report
  30. Pharmacological and null mutation approaches reveal nicotinic receptor diversity
    Paul Whiteaker, Michael J. Marks, Sharon R. Grady, Ying Lü, Marina R. Picciotto, Jean‐Pierre Changeux, Allan C. Collins · 2000 · European Journal of Pharmacology
  31. Adolescent Drug Addiction Treatment and Weight Gain
    Candace C. Hodgkins, Kevin S. Cahill, Anne E. Seraphine, Kimberly Frost-Pineda, Mark S. Gold · 2004 · Journal of Addictive Diseases
  32. The role of 5‐HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration
    Survjit Cheeta, Paul J. Kenny, Sandra E. File · 2000 · European Journal of Neuroscience
  33. The effects of morphine in the consummatory contrast paradigm
    Grace A. Rowan‐Szal, Charles F. Flaherty · 1987 · Psychopharmacology
  34. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
    Andrew N. Gifford, Magalie Bruneus, Sonyuan Lin · 1999 · European Journal of Pharmacology
  35. Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat
    Ming D. Li, Justin K. Kane · 2003 · Brain Research
  36. The Endocannabinoid System: Current Pharmacological Research and Therapeutic Possibilities
    Kent‐Olov Jonsson, Sandra Holt, Christopher John Fowler · 2006 · Basic & Clinical Pharmacology & Toxicology
  37. Chronic inhibition of α4β2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response
    David B. Arthur, Edward Levin · 2002 · Psychopharmacology
  38. Effects of smoking cessation, restrained eating, and motivational states on food intake in the laboratory.
    Jane Ogden · 1994 · Health Psychology
  39. Relationship of negative contrast to animal models of fear and anxiety
    Charles F. Flaherty, Anna Greenwood, Joseph V. Martin, Mary Leszczuk · 1998 · Animal Learning & Behavior
  40. Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
    Arguello, P. Alexander, Jentsch, J. David · 2004 · Psychopharmacology
  41. Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
    John R. Hughes, Steven W. Gust, Robert M. Keenan, James W. Fenwick · 1990 · Journal of Pharmacology and Experimental Therapeutics
  42. Repeated, Intermittent Δ9-Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visuospatial Divided Attention
    Christopher D. Verrico, James David Jentsch, Robert Howard Roth, Jane R. Taylor · 2003 · Neuropsychopharmacology
  43. Effects of tobacco abstinence on food intake among cigarette smokers.
    Dorothy K. Hatsukami, Lynda Paulson LaBounty, John R. Hughes, Dawn C. Laine · 1993 · Health Psychology
  44. Spatial signal detection in rats is differentially disrupted by Δ-9-tetrahydrocannabinol, scopolamine, and MK-801
    Gadi Presburger, John K. Robinson · 1999 · Behavioural Brain Research
  45. Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity
    Kenneth A. Perkins, Joan E. Sexton, Richard L. Stiller, Carolyn A. Fonte, Amy DiMarco, Jennifer Goettler, Annette M. Scierka · 1994 · Psychopharmacology
  46. Antagonism of the anxiolytic effect of nicotine in the dorsal raphé nucleus by dihydro-β-erythroidine
    Survjit Cheeta, Sonia A. Tucci, Sandra E. File · 2001 · Pharmacology Biochemistry and Behavior
  47. Late adolescent female smoking
    Marilyn Seguire, Karen I. Chalmers · 2000 · Journal of Advanced Nursing
  48. Modulators of nicotinic acetylcholine receptors as analgesics.
    Kewal K. Jain · 2004 · PubMed
  49. Effects of nicotine on hunger and eating in male and female smokers
    Kenneth A. Perkins, Leonard H. Epstein, Joan E. Sexton, RENA D. SOLBERG-KASSEL, Richard L. Stiller, Rolf G. Jacob · 1992 · Psychopharmacology
  50. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats
    Janusz Szyndler, Halina Sienkiewicz‐Jarosz, Piotr Maciejak, Marek Siemiątkowski, D Rokicki, Anna Członkowska, Adam Płaźnik · 2001 · Pharmacology Biochemistry and Behavior
  51. Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: A test of incremental predictive validity among young adult regular smokers
    Michael J. Zvolensky, Matthew T. Feldner, Ellen W. Leen‐Feldner, Laura E. Gibson, Kenneth B. Abrams, Kristin L. Gregor · 2005 · Behaviour Research and Therapy
  52. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat
    Hirotsugu Okuda, Seiji Shioda, Yasumitsu Nakai · 1993 · Neuroscience Letters
  53. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis
    Sandra E. File · 1990 · Pharmacology & Therapeutics
  54. Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety
    Tucci, Sonia, Cheeta, Survjit, Seth, Pallab, File, Sandra E. · 2003 · Psychopharmacology
  55. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats
    Eva María Marco, Ricardo Llorente, E. Moreno, José Miguel Biscaia Fernández, Carmen Guaza, María‐Paz Viveros · 2006 · Behavioural Brain Research
  56. Behavioural pharmacology of nicotine: multiple mechanisms
    Ian P. Stolerman · 1991 · British Journal of Addiction
  57. Nicotine's opioid and anti-opioid interactions: Proposed role in smoking behavior
    Mario D. G. Aceto, Susan M. Scates, Zhen Ji, Edward R. Bowman · 1993 · European Journal of Pharmacology Environmental Toxicology and Pharmacology
  58. Conditions under which amobarbital sodium influences contrast in consummatory behavior
    Charles F. Flaherty, Howard C. Becker, Cynthia D. Driscoll · 1982 · Physiological Psychology
  59. Chlordiazepoxide and the moderation of the initial response to reward reduction.
    Charles F. Flaherty, Patricia S. Grigson, Susanne Lind · 1990 · PubMed
  60. Effects of delta 9-tetrahydrocannabinol on sensory-evoked discharges of granule cells in the dentate gyrus of behaving rats.
    K. A. Campbell, Thomas C. Foster, Robert E. Hampson, S. A. Deadwyler · 1986 · Journal of Pharmacology and Experimental Therapeutics
  61. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus.
    K. A. Campbell, Thomas C. Foster, Robert E. Hampson, S. A. Deadwyler · 1986 · Journal of Pharmacology and Experimental Therapeutics
  62. Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking
    Petra Netter, Juergen Hennig, Sonja Huwe, Robert Olbrich · 1998 · Psychopharmacology
  63. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects
    Elaine E. Irvine, Survjit Cheeta, Melanie J. Marshall, Sandra E. File · 2001 · Pharmacology Biochemistry and Behavior
  64. Mood differences between male and female light smokers and nonsmokers
    Sandra E. File, Abigail K Dinnis, Joy E Heard, Elaine E. Irvine · 2002 · Pharmacology Biochemistry and Behavior
  65. The κ-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety
    Eva María Marco, Ricardo Llorente, Laura Pérez-Álvarez · 2005 · Behavioural Brain Research
  66. Dietary Restriction and Nicotine can Reduce Anxiety in Female Rats
    Rachel F. Genn, Sonia A. Tucci, Jessica E Edwards, Sandra E. File · 2003 · Neuropsychopharmacology
  67. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
    Rachel F. Genn, Sonia A. Tucci, Sunny Parikh, Sandra E. File · 2004 · Psychopharmacology
  68. An investigation into the effects of nicotine gum on short-term memory
    Sarah Phillips, Pauline Fox · 1998 · Psychopharmacology
  69. Acute pharmacodynamic tolerance to the subjective effects of cigarette smoking
    Andrew C. Parrott · 1994 · Psychopharmacology
  70. Associations between tobacco and cannabis use in remote indigenous populations in Northern Australia
    ALAN R. CLOUGH · 2005 · Addiction
  71. Nicotine and Endogenous Opioids: Toward Specific Pharmacotherapy
    Zahinoor Ismail, Nady el‐Guebaly · 1998 · The Canadian Journal of Psychiatry
  72. Development of tolerance to nicotine’s anxiogenic effect in the social interaction test
    Elaine E. Irvine, Survjit Cheeta, Sandra E. File · 2001 · Brain Research
  73. Conditioned anxiety to nicotine
    Sandra E. File, Survjit Cheeta, Elaine E. Irvine, Sonia A. Tucci, Morium Akthar · 2002 · Psychopharmacology
  74. The association of testosterone with nicotine use in young adult females
    Catherine Anne Martin, TK Logan, Charity Portis, Carl G. Leukefeld, Donald R. Lynam, Michele Staton, Bethanie Brogli, Kate Flory, Richard Clayton · 2001 · Addictive Behaviors
  75. Do different mechanisms underlie two anxiogenic effects of systemic nicotine?
    Sonia A. Tucci, Rachel F. Genn, Eva María Marco · 2003 · Behavioural Pharmacology
  76. Tolerance to midazolam's anxiolytic effects after short-term nicotine treatment
    Elaine E. Irvine, Survjit Cheeta, Claire Lovelock, Sandra E. File · 2001 · Neuropharmacology
  77. Extrahypothalamic corticotropin-releasing hormone mediates (−)-nicotine-induced elevation of plasma corticosterone in rats
    Shoshiro Okada, Takahiro Shimizu, Kunihiko Yokotani · 2003 · European Journal of Pharmacology
  78. Effect of prolonged nicotine infusion on response of rat catecholamine biosynthetic enzymes to restraint and cold stress
    Shu‐Yuan Cheng, Dina Viktorovna Glazkova, Lidia I. Serova, Esther Louise Sabban · 2005 · Pharmacology Biochemistry and Behavior
  79. Anxiety conditioned to nicotine in the elevated plus-maze is time dependent
    Sonia A. Tucci, Survjit Cheeta, Rachel F. Genn, Pallab Seth, Sandra E. File · 2002 · Behavioural Pharmacology
  80. Changes in food consumption and body weight associated with smoking cessation across menstrual cycle phase
    Linda H. Eck, Robert C. Klesges, Andrew W. Meyers, DEBORAH LEACHMAN SLAWSON, Suzan E. Winders · 1997 · Addictive Behaviors
  81. Cannabinoids, anxiety and depression.
    María‐Paz Viveros, Eva María Marco, J. N. Govil · 2007
  82. Emerging targets for the treatment of depressive disorder
    Allan Hunter Young, Karine Macritchie · 2001 · Expert Opinion on Therapeutic Targets
  83. Nicotinic involvement in ACh-DA interaction?
    Susan Wonnacott · 1989 · Trends in Pharmacological Sciences